s6y

4/A ALNYLAM PHARMACEUTICALS INC: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001209191-04-030076

Documents

  1. MAIN DOCUMENT DESCRIPTION 4/A
  2. MAIN DOCUMENT DESCRIPTION 4/A

On sec.gov